Elacridar, ≥98%

Catalog No. 227345

General Information

Synonyms	GF120918, GG918, GW0918
CAS No.	143664-11-3
M.F.	C₃₄H₃₃N₃O₅
M.W.	563.64
MDL No.	MFCD00912604

Technical Data

Assay	≥98% HPLC
Solubility	DMSO
Storage	-20℃
Description	Elacridar is a potent inhibitor of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP).

Reference

Bankstahl JP, et al. Drug Metab Dispos. 2013 Apr;41(4):754-62
Durmus S, et al. Mol Pharm. 2012 Nov 5;9(11):3236-45
Sane R, et al. Drug Metab Dispos. 2012 Aug;40(8):1612-9
Kuppens IE, et al. Clin Cancer Res. 2007 Jun 1;13(11):3276-85

Size	Price	Quantity	Favorites
25 mg	USD96
50 mg	USD175
100 mg	USD296
500 mg	USD880

Please inquire for non-standard packs and bulk quantities.

Availability: Ships in 1-3 days

For research use only. Not for human use.

> Certificate of Analysis

> MSDS

	(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject	227345, Elacridar, ≥98%, 143664-11-3
*Message
*Code

Elacridar, ≥98%

Inquire